KZR (Kezar Life Sciences, Inc) Bathi resik saben saham (EPS TTM)

Supply chain optimization for immunological components supports high margins for Kezar Life Sciences (KZR). The annual EPS TTM YoY trend demonstrates current profit dynamics, where the value 43.10 captures this metric. Demand for the treatment of autoimmune pathologies remains independent of economic cycles. The company is currently reducing costs and focusing on its own preclinical developments without external mergers.
Kezar Life Sciences Inc. - rincian analitis lan metrik utama (KZR)

Year-over-year (YoY) EPS growth (TTM) measures the annual trend of net income per share over a rolling period, capturing the actual amplitude of change in return on equity. By analyzing this chart of YoY TTM earnings per share growth rates, an investor can see the dependence of Kezar Life Sciences (KZR) on external financing and partner payments, which renders any decline in this indicator a critical signal of financial instability.